Top Markets
Coin of the day
IR Biosciences Holdings Inc. IR Biosciences Holdings Inc.

IR Biosciences Holdings Inc.

IRBS
株式のランク #40519
IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm.... IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation. The company is also actively developing Homspera and its derivatives, Radilex and Viprovex. These compounds are designed to stimulate human stem cells, enhance immune system responses, offer anti-infective properties, serve as vaccine adjuvants, and promote wound healing. Founded in 1999, IR BioSciences Holdings, Inc. maintains its headquarters in Scottsdale, Arizona.
株価
$0.00006
最終同期: 2025-07-15
時価総額
$128.12K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 IR Biosciences Holdings Inc. (IRBS)

カテゴリー

IR Biosciences Holdings Inc.(IRBS)のEPS
2026 時点のEPS TTM: 0
IR Biosciences Holdings Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
IR Biosciences Holdings Inc.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS